The number of people with susceptibility test result for rifampicin in Chile

Chile: The number of people with susceptibility test result for rifampicin was 1,772 in 2021. ▬ Flat

Latest (2021)
1,772
Change on year
up 17.4%
World rank
53rd
of 155 countries
All-time high
1,887
in 2019
All-time low
1,510
in 2020
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Chile, 2017–2021

05001.0k1.5k2.0k2017201920212017: 1.6k2018: 1.7k2019: 1.9k2020: 1.5k2021: 1.8k

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for the number of people with susceptibility test result for rifampicin in Chile is 1,772, measured in 2021.

The figure is up 17.4% on the previous year and up 12.4% over five years.

That places Chile 53rd out of 155 countries with data for 2021, putting it in the middle of the range.

The number of people with susceptibility test result for rifampicin in Chile, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Chile, 2017 to 2021.
Year Value Change
2017 1,577
2018 1,698 +7.7%
2019 1,887 +11.1%
2020 1,510 -20.0%
2021 1,772 +17.4%

Chile compared with similar countries

  • Chile's 1,772 is above the median for high income countries, which is 142, 12.5× the median. (61 countries reporting)
  • Chile's 1,772 is above the median for Latin America & Caribbean, which is 406.5, 4.4× the median. (26 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 1,721 1,577 1,887 3
2020s 1,641 1,510 1,772 2

Countries ranked near Chile

  1. 50 Tajikistan 1,862 compare
  2. 51 Iran, Islamic Republic of 1,828 compare
  3. 52 Togo 1,805 compare
  4. 54 United Kingdom of Great Britain and Northern Ireland 1,734 compare
  5. 55 Dominican Republic 1,724 compare
  6. 56 Paraguay 1,639 compare

See the full ranking of 157 places →

More health data for Chile

All data for Chile →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Chile?
The number of people with susceptibility test result for rifampicin in Chile was 1,772 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Chile?
The highest recorded value was 1,887 in 2019.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Chile?
The lowest recorded value was 1,510 in 2020.
How does Chile rank for the number of people with susceptibility test result for rifampicin?
Chile ranks 53rd out of 155 countries with data for 2021.
Where does this Chile data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Chile. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 14 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/chile/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/chile/">The number of people with susceptibility test result for rifampicin in Chile</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed